A novel comprehensive breakpoint-targeted assay for clinically actionable RNA fusions and aberrant RNAs in solid tumors. Read more about A novel comprehensive breakpoint-targeted assay for clinically actionable RNA fusions and aberrant RNAs in solid tumors.
A comprehensive genomic profiling approach to detect functional translocations and genomic alterations in a single tube workflow Read more about A comprehensive genomic profiling approach to detect functional translocations and genomic alterations in a single tube workflow
TP53/NPM1-Mutated Acute Myeloid Leukemia as a Molecularly Distinct Disease Entity Read more about TP53/NPM1-Mutated Acute Myeloid Leukemia as a Molecularly Distinct Disease Entity
Residual ctDNA after treatment predicts early relapse in patients with early stage non-small cell lung cancer Read more about Residual ctDNA after treatment predicts early relapse in patients with early stage non-small cell lung cancer
Real time clinical utility of ctDNA genomic alterations in untreated patients with advanced NSCLC Read more about Real time clinical utility of ctDNA genomic alterations in untreated patients with advanced NSCLC
Personalised circulating cell-free tumour DNA analysis for detection of minimal residual disease and recurrence in patients with head and neck squamous cell carcinoma Read more about Personalised circulating cell-free tumour DNA analysis for detection of minimal residual disease and recurrence in patients with head and neck squamous cell carcinoma
Clinical utility of ctDNA for detection of EGFR, ALK, BRAFV600E alterations and resistance mutations in patients with NSCLC at failure to targeted therapy Read more about Clinical utility of ctDNA for detection of EGFR, ALK, BRAFV600E alterations and resistance mutations in patients with NSCLC at failure to targeted therapy
A personalised sequencing approach for liquid biopsy-based detection of recurrent disease in early-stage breast cancer Read more about A personalised sequencing approach for liquid biopsy-based detection of recurrent disease in early-stage breast cancer
Multiplex Immunofluorescence Assay, MultiOmyx: Detection and deep profiling of immune cells in HBV-infected liver biopsies Read more about Multiplex Immunofluorescence Assay, MultiOmyx: Detection and deep profiling of immune cells in HBV-infected liver biopsies
A novel cross-site analysis of Vectra® Polaris™ multiplex fluorescence PD-1/PD-L1 immunohistochemistry on colorectal cancer with high and low microsatellite instability Read more about A novel cross-site analysis of Vectra® Polaris™ multiplex fluorescence PD-1/PD-L1 immunohistochemistry on colorectal cancer with high and low microsatellite instability